The U.S. Food and Drug Administration (FDA) has found new manufacturing lapses at Eli Lilly's (NYSE:LLY) Branchburg, New Jersey, plant, which has already been under regulatory scrutiny ...

Eli Lilly faced renewed scrutiny in January as the FDA inspectors revealed additional manufacturing issues at its Branchburg, New Jersey plant. Trending: Saudi Arabia Seeks US Defense Pact ...

Drugmaker Eli Lilly and Co. will invest $3 billion and ... North Carolina; and Branchburg, New Jersey. Real estate projects featuring new construction and redevelopments continue to reshape ...